Artivion Inc (AORT)
23.56
+0.43
(+1.86%)
USD |
NYSE |
Jun 25, 16:00
23.54
-0.02
(-0.06%)
After-Hours: 20:00
Artivion Research and Development Expense (Annual): 28.71M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 28.71M |
| December 31, 2022 | 38.88M |
| December 31, 2021 | 35.55M |
| December 31, 2020 | 24.21M |
| December 31, 2019 | 22.96M |
| December 31, 2018 | 23.10M |
| December 31, 2017 | 19.46M |
| December 31, 2016 | 13.45M |
| December 31, 2015 | 10.44M |
| December 31, 2014 | 8.699M |
| December 31, 2013 | 8.454M |
| December 31, 2012 | 7.257M |
| December 31, 2011 | 6.899M |
| December 31, 2010 | 9.436M |
| Date | Value |
|---|---|
| December 31, 2009 | 5.247M |
| December 31, 2008 | 5.309M |
| December 31, 2007 | 4.453M |
| December 31, 2006 | 3.547M |
| December 31, 2005 | 3.724M |
| December 31, 2004 | 3.938M |
| December 31, 2003 | 3.644M |
| December 31, 2002 | 4.597M |
| December 31, 2001 | 4.737M |
| December 31, 2000 | 5.207M |
| December 31, 1999 | 4.396M |
| December 31, 1998 | 4.70M |
| December 31, 1997 | 3.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
22.96M
Minimum
2019
38.88M
Maximum
2022
30.06M
Average
28.71M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Align Technology Inc | 346.83M |
| ThermoGenesis Holdings Inc | 1.284M |
| NeuroOne Medical Technologies Corp | 6.941M |
| SINTX Technologies Inc | 8.713M |
| Nutriband Inc | 1.960M |